Aap Implantate AG (AAQ)

BRIEF

published on 07/15/2024 at 07:35, 4 months 6 days ago

Aap Implantate AG Reports Positive Sales Growth for Q2 and H1 2024

Medical Technology Sales Growth Clinical Trials Market Expansion Regional Performance
PRESS RELEASE

published on 07/15/2024 at 07:30, 4 months 6 days ago

Sales growth Q2/2024 +14 % and H1/2024 +10 % compared to previous year; positive development in all operating areas
aap Implantate AG reports sales growth of 14% in Q2/2024 and 10% in H1/2024 compared to the previous year, with positive developments across all operating regions

Sales Growth Aap Implantate AG Antibacterial Implant Technology Q2/2024 H1/2024
BRIEF

published on 05/23/2024 at 19:10, 5 months 28 days ago

Aap Implantate AG Completes Amendment to Bond Terms, Allows Conversion to Shares

Shares Financial News Aap Implantate AG Bonds Conversion
PRESS RELEASE

published on 05/23/2024 at 19:05, 5 months 28 days ago

Amendment of the terms and conditions of the bond completed; Bondholders can convert bonds into shares
aap Implantate AG completes amendment of bond terms allowing bondholders to convert bonds into shares. Conversion period until May 29, 2024. For more information, visit https://www.aap.de/investoren/wandelschuldverschreibung

Medical Technology Investment Aap Implantate AG Bond Amendment Conversion Into Shares
BRIEF

published on 04/22/2024 at 07:35, 6 months 29 days ago

Aap Implantate AG Reports 5.6% Sales Growth in Q1 2024

Aap Implantate AG Financial Growth Q1 2024 Sales Antibacterial Implant Technology MDR Authorization
PRESS RELEASE

published on 04/22/2024 at 07:30, 6 months 29 days ago

aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024
aap Implantate AG reports 5.6% sales growth in Q1 2024, positive developments across all regions & progress in human clinical trial of antibacterial implant technology

Sales Growth Clinical Trial Aap Implantate AG Q1 2024 Antibacterial Technology
BRIEF

published on 04/19/2024 at 07:35, 7 months 2 days ago

Aap Implantate AG Announces Successful 10% Capital Increase

Medical Technology Capital Increase Aap Implantate AG Financial Strategy Antibacterial Implant Technology
PRESS RELEASE

published on 04/19/2024 at 07:30, 7 months 2 days ago

aap successfully places a 10% capital increase from authorized capital at EUR 1.10 with exclusion of subscription rights
aap Implantate AG successfully completes 10% capital increase at EUR 1.10, raising EUR 986,311.70 for human clinical trial of antibacterial implant technology

Capital Increase Authorized Capital Clinical Trial Aap Implantate AG Antibacterial Implant Technology
BRIEF

published on 04/17/2024 at 19:02, 7 months 3 days ago

Aap Implantate AG Delays 2023 Financial Report Release Due to Staffing Issues

Annual General Meeting Aap Implantate AG Financial Statements Delay Staff Shortages Auditing Changes
PRESS RELEASE

published on 04/17/2024 at 18:57, 7 months 3 days ago

EQS-Adhoc: aap Implantate AG: aap postpones publication of the consolidated financial statements 2023 due to staff shortages
aap Implantate AG postpones the publication of the consolidated financial statements 2023 due to staff shortages. The Annual General Meeting may also be affected by this delay

Consolidated Financial Statements Annual General Meeting Aap Implantate AG Postponement Staff Shortages

Published on 11/21/2024 at 16:30, 35 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 4 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 5 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 16:00, 1 hour 5 minutes ago

Wiz Acquires Dazz to Revolutionize Cloud Security Remediation
Published on 11/21/2024 at 16:00, 1 hour 5 minutes ago

Isaac Ullatil Joins Wellstack Board of Directors

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 1 hour 5 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 1 hour 23 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 1 hour 41 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 1 hour 42 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 1 hour 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 7 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 21 hours 45 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 23 hours 20 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 23 hours 20 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 9 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE

News